...
首页> 外文期刊>Parasitology >Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
【24h】

Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art

机译:作为发现新的反利尔诺的发现的策略:最先进的

获取原文
获取原文并翻译 | 示例
           

摘要

Leishmaniasis is a vector-borne neglected tropical disease caused by protozoan parasites of the genus Leishmania for which there is a paucity of effective viable non-toxic drugs. There are 1.3 million new cases each year causing considerable socioeconomic hardship, best measured in 2.4 million disability adjusted life years, with greatest impact on the poorest communities, which means that desperately needed new antileishmanial treatments have to be both affordable and accessible. Established medicines with cheaper and faster development times may hold the cure for this neglected tropical disease. This concept of using old drugs for new diseases may not be novel but, with the ambitious target of controlling or eradicating tropical diseases by 2020, this strategy is still an important one. In this review, we will explore the current state-of-the-art of drug repurposing strategies in the search for new treatments for leishmaniasis.
机译:Leishmaniaisis是由莱山岛属的原生动物寄生虫引起的矢量传播的热带病,其中缺乏有效的活性无毒药物。 每年有130万新案例,造成相当大的社会经济困难,在240万残疾调整后的生活年份,对最贫穷的社区产生了最大的影响,这意味着迫切需要新的抗恋的治疗必须是价格实惠和可取的。 具有更便宜和更快的发展时期的已建立药物可能对这种被忽视的热带疾病进行治愈。 这种概念对新疾病的使用旧药物可能不是新颖的,但是,在2020年到2020年控制或消除热带疾病的雄心勃勃的目标,这种策略仍然是一个重要的目标。 在这篇综述中,我们将探讨目前在寻找LeishManiaisis的新治疗中的药物修复策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号